BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 34048566)

  • 1. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
    Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
    J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway.
    Teimouri M; Hosseini H; Shabani M; Koushki M; Noorbakhsh F; Meshkani R
    IUBMB Life; 2020 Mar; 72(3):361-372. PubMed ID: 31889412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
    Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
    Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic lipid accumulation induced by a high-fat diet is regulated by Nrf2 through multiple pathways.
    Qiu S; Liang Z; Wu Q; Wang M; Yang M; Chen C; Zheng H; Zhu Z; Li L; Yang G
    FASEB J; 2022 May; 36(5):e22280. PubMed ID: 35394671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance.
    Meakin PJ; Chowdhry S; Sharma RS; Ashford FB; Walsh SV; McCrimmon RJ; Dinkova-Kostova AT; Dillon JF; Hayes JD; Ashford ML
    Mol Cell Biol; 2014 Sep; 34(17):3305-20. PubMed ID: 24958099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice.
    Lee LY; Köhler UA; Zhang L; Roenneburg D; Werner S; Johnson JA; Foley DP
    Toxicol Sci; 2014 Dec; 142(2):361-74. PubMed ID: 25294219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation.
    Feng X; Yu W; Li X; Zhou F; Zhang W; Shen Q; Li J; Zhang C; Shen P
    Biochem Pharmacol; 2017 Jul; 136():136-149. PubMed ID: 28414138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
    Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
    Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet.
    Liu Z; Dou W; Ni Z; Wen Q; Zhang R; Qin M; Wang X; Tang H; Cao Y; Wang J; Zhao S
    Mol Med Rep; 2016 Aug; 14(2):1323-31. PubMed ID: 27315552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression.
    Li L; Fu J; Liu D; Sun J; Hou Y; Chen C; Shao J; Wang L; Wang X; Zhao R; Wang H; Andersen ME; Zhang Q; Xu Y; Pi J
    Redox Biol; 2020 Feb; 30():101412. PubMed ID: 31901728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model.
    Zhu CG; Liu YX; Wang H; Wang BP; Qu HQ; Wang BL; Zhu M
    Endocr J; 2017 Jul; 64(7):663-673. PubMed ID: 28539530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siphonaxanthin, a carotenoid from green algae Codium cylindricum, protects Ob/Ob mice fed on a high-fat diet against lipotoxicity by ameliorating somatic stresses and restoring anti-oxidative capacity.
    Zheng J; Manabe Y; Sugawara T
    Nutr Res; 2020 May; 77():29-42. PubMed ID: 32315893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation.
    Yuan J; Yu Z; Gao J; Luo K; Shen X; Cui B; Lu Z
    Redox Biol; 2022 Feb; 49():102224. PubMed ID: 34954499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.
    Cui Y; Wang Q; Li X; Zhang X
    Redox Biol; 2013; 1(1):433-40. PubMed ID: 24191237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effect of
    Shrestha J; Baek DJ; Oh YS; Cho SS; Ki SH; Park EY
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
    Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism.
    Chambel SS; Santos-Gonçalves A; Duarte TL
    Biomed Res Int; 2015; 2015():597134. PubMed ID: 26120584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Octyl Itaconate Prevents Free Fatty Acid-Induced Lipid Metabolism Disorder through Activating Nrf2-AMPK Signaling Pathway in Hepatocytes.
    Chu X; Li L; Yan W; Ma H
    Oxid Med Cell Longev; 2022; 2022():5180242. PubMed ID: 35222799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.